CN1043349C - 新的糖醇硫酸酯其制备方法及其应用 - Google Patents

新的糖醇硫酸酯其制备方法及其应用 Download PDF

Info

Publication number
CN1043349C
CN1043349C CN95101166A CN95101166A CN1043349C CN 1043349 C CN1043349 C CN 1043349C CN 95101166 A CN95101166 A CN 95101166A CN 95101166 A CN95101166 A CN 95101166A CN 1043349 C CN1043349 C CN 1043349C
Authority
CN
China
Prior art keywords
glucitol
sulfo
penta
bis
ylamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN95101166A
Other languages
English (en)
Chinese (zh)
Other versions
CN1109889A (zh
Inventor
A·查乔罗斯基
J·芬格尔
H·P·马金
R马勒
M皮奇
M拉格
G施米德
T楚波
H·P·维瑟尔
N艾博格
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of CN1109889A publication Critical patent/CN1109889A/zh
Application granted granted Critical
Publication of CN1043349C publication Critical patent/CN1043349C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C305/00—Esters of sulfuric acids
    • C07C305/02—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C305/04—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton being acyclic and saturated
    • C07C305/10—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton being acyclic and saturated being further substituted by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C305/00—Esters of sulfuric acids
    • C07C305/02—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C305/04—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton being acyclic and saturated
    • C07C305/06—Hydrogenosulfates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/17—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C317/22—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C317/34—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
    • C07C317/36—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atoms of the amino groups bound to hydrogen atoms or to carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Vascular Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Seasonings (AREA)
  • Laser Surgery Devices (AREA)
  • Steroid Compounds (AREA)
CN95101166A 1994-01-14 1995-01-11 新的糖醇硫酸酯其制备方法及其应用 Expired - Fee Related CN1043349C (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH11494 1994-01-14
CH114/94 1994-01-14
CH331594 1994-11-07
CH3315/94 1994-11-07

Publications (2)

Publication Number Publication Date
CN1109889A CN1109889A (zh) 1995-10-11
CN1043349C true CN1043349C (zh) 1999-05-12

Family

ID=25683559

Family Applications (1)

Application Number Title Priority Date Filing Date
CN95101166A Expired - Fee Related CN1043349C (zh) 1994-01-14 1995-01-11 新的糖醇硫酸酯其制备方法及其应用

Country Status (21)

Country Link
US (1) US5521160A (cg-RX-API-DMAC10.html)
EP (1) EP0663391B1 (cg-RX-API-DMAC10.html)
JP (1) JP2862489B2 (cg-RX-API-DMAC10.html)
KR (1) KR950032111A (cg-RX-API-DMAC10.html)
CN (1) CN1043349C (cg-RX-API-DMAC10.html)
AT (1) ATE151416T1 (cg-RX-API-DMAC10.html)
AU (1) AU685196B2 (cg-RX-API-DMAC10.html)
CA (1) CA2139720A1 (cg-RX-API-DMAC10.html)
CZ (1) CZ8395A3 (cg-RX-API-DMAC10.html)
DE (1) DE59500162D1 (cg-RX-API-DMAC10.html)
DK (1) DK0663391T3 (cg-RX-API-DMAC10.html)
ES (1) ES2101583T3 (cg-RX-API-DMAC10.html)
FI (1) FI950127L (cg-RX-API-DMAC10.html)
GR (1) GR3024012T3 (cg-RX-API-DMAC10.html)
HU (1) HUT72412A (cg-RX-API-DMAC10.html)
IL (1) IL112284A (cg-RX-API-DMAC10.html)
NO (1) NO302817B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ270316A (cg-RX-API-DMAC10.html)
RU (1) RU2139854C1 (cg-RX-API-DMAC10.html)
TW (1) TW308598B (cg-RX-API-DMAC10.html)
UA (1) UA42696C2 (cg-RX-API-DMAC10.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR199600329A2 (tr) * 1995-05-05 1997-03-21 Hoffmann La Roche Seker alkollerin yeni sülfürik asit esterleri.
CA2174582A1 (en) * 1995-05-05 1996-11-06 Alexander Chucholowski Sulphuric acid esters of amino-sugars
US6331633B1 (en) 1998-05-08 2001-12-18 Calyx Therapeutics Inc. Heterocyclic analogs of diphenylethylene compounds
US6624197B1 (en) 1998-05-08 2003-09-23 Calyx Therapeutics, Inc. Diphenylethylene compounds
US6245814B1 (en) 1998-05-08 2001-06-12 Calyx Therapeutics, Inc. Diphenylethylene compounds
US7105552B2 (en) 1998-05-08 2006-09-12 Theracos, Inc. Heterocyclic analogs of diphenylethylene compounds
EP1109545A4 (en) * 1998-09-11 2004-11-10 Ilexus Pty Ltd MODULATORS OF THE Fc RECEPTOR AND USE OF SUCH MODULATORS
US7407978B2 (en) * 1999-04-06 2008-08-05 Theracos, Inc. Heterocyclic analogs of diphenylethylene compounds
US20080108825A1 (en) * 1999-11-08 2008-05-08 Theracos, Inc. Compounds for treatment of inflammation, diabetes and related disorders
US7323496B2 (en) * 1999-11-08 2008-01-29 Theracos, Inc. Compounds for treatment of inflammation, diabetes and related disorders
US20020002200A1 (en) * 2000-02-04 2002-01-03 Bishwagit Nag Novel diphenylethylene compounds
US6525093B1 (en) 1999-11-08 2003-02-25 Calyx Therapeutics Inc. Compounds to treat diabetes and associated conditions
US20080103302A1 (en) * 2000-02-04 2008-05-01 Theracos, Inc. Compounds for treatment of inflammation, diabetes and related disorders
EP1360167A1 (en) * 2001-01-16 2003-11-12 Guilford Pharmaceuticals Inc. Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use
GB0228410D0 (en) 2002-12-05 2003-01-08 Glaxo Group Ltd Novel Compounds
WO2004052962A1 (ja) * 2002-12-11 2004-06-24 Nissan Chemical Industries, Ltd. 新規なジアミノベンゼン誘導体、それを用いたポリイミド前駆体およびポリイミド、並びに液晶配向処理剤
JP6051998B2 (ja) * 2012-03-30 2016-12-27 日油株式会社 マルチアーム型ポリエチレングリコール誘導体、その中間体及び製造方法
MX2014014174A (es) * 2012-05-22 2015-07-06 Hoffmann La Roche Inhibidores selectivos de celulas no diferenciadas.
CN110092737B (zh) * 2018-01-31 2022-06-17 海思美域(深圳)科技有限公司 一种抗静电化合物、材料的表面处理方法及改性材料

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0312086A2 (de) * 1987-10-14 1989-04-19 LUITPOLD PHARMA GmbH Polyschwefelsäureester von Bis-aldonsäureamiden und deren Derivaten, Verfahren zu ihrer Herstellung und Arzneimittel
EP0479093A1 (de) * 1990-10-03 1992-04-08 F. Hoffmann-La Roche Ag Oligosaccharidderivate und deren Verwendung in Heilmitteln
EP0504645A2 (de) * 1991-03-13 1992-09-23 F. Hoffmann-La Roche Ag Verwendung von sulfatierten Oligosacchariden zur Behandlung arteriosklerotischer Erkrankungen und zur Verhinderung der Restenosierung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH621796A5 (en) * 1976-06-28 1981-02-27 Hoffmann La Roche Process for the preparation of an antibiotic
DE3734853A1 (de) * 1987-10-14 1989-04-27 Luitpold Werk Chem Pharm Bis-aldonsaeureamide und verfahren zu ihrer herstellung

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0312086A2 (de) * 1987-10-14 1989-04-19 LUITPOLD PHARMA GmbH Polyschwefelsäureester von Bis-aldonsäureamiden und deren Derivaten, Verfahren zu ihrer Herstellung und Arzneimittel
EP0479093A1 (de) * 1990-10-03 1992-04-08 F. Hoffmann-La Roche Ag Oligosaccharidderivate und deren Verwendung in Heilmitteln
EP0504645A2 (de) * 1991-03-13 1992-09-23 F. Hoffmann-La Roche Ag Verwendung von sulfatierten Oligosacchariden zur Behandlung arteriosklerotischer Erkrankungen und zur Verhinderung der Restenosierung

Also Published As

Publication number Publication date
US5521160A (en) 1996-05-28
IL112284A0 (en) 1995-03-30
KR950032111A (ko) 1995-12-20
HUT72412A (en) 1996-04-29
CZ8395A3 (en) 1995-11-15
EP0663391B1 (de) 1997-04-09
IL112284A (en) 1998-10-30
NZ270316A (en) 1996-08-27
ATE151416T1 (de) 1997-04-15
FI950127A0 (fi) 1995-01-11
CN1109889A (zh) 1995-10-11
JP2862489B2 (ja) 1999-03-03
AU1010695A (en) 1995-07-27
JPH07206803A (ja) 1995-08-08
TW308598B (cg-RX-API-DMAC10.html) 1997-06-21
RU95100773A (ru) 1996-10-27
NO950137L (no) 1995-07-17
NO950137D0 (no) 1995-01-13
GR3024012T3 (en) 1997-10-31
FI950127A7 (fi) 1995-07-15
DK0663391T3 (da) 1997-10-20
FI950127L (fi) 1995-07-15
AU685196B2 (en) 1998-01-15
ES2101583T3 (es) 1997-07-01
DE59500162D1 (de) 1997-05-15
EP0663391A1 (de) 1995-07-19
RU2139854C1 (ru) 1999-10-20
NO302817B1 (no) 1998-04-27
UA42696C2 (uk) 2001-11-15
CA2139720A1 (en) 1995-07-15

Similar Documents

Publication Publication Date Title
CN1043349C (zh) 新的糖醇硫酸酯其制备方法及其应用
CN1127479C (zh) 磺酰脲衍生物及其在白介素－1活性的控制中的用途
CN1161331C (zh) 肼衍生物
CN1036650C (zh) 磺酰胺衍生物的制备方法
CN1090612C (zh) 氧代和羟基取代的烃的胺衍生物
CN1462268A (zh) 取代的肉桂酸胍化物、其制备方法、其作为药物的应用、以及含有这些化合物的药物
CN1097737A (zh) 取代的苯甲酰胍、其制法和含有它们的药物及应用
CN1237961A (zh) 用作蛋白酶抑制剂的氨基胍和烷氧基胍类化合物
CN1177351A (zh) 用于增强分子伴娘素产生的羟胺衍生物及其制备
CN1596240A (zh) 查耳酮衍生物及其治疗疾病的用途
CN1247529A (zh) 磺酰胺和羧酰胺衍生物和含这种化合物作活性成分的药物
CN1306509A (zh) 取代苯甲酰胺类、其制备以及作为半胱氨酸蛋白酶抑制剂的应用
CN1430600A (zh) 7－和9－氨基甲酸酯、脲、硫脲、硫代氨基甲酸酯,和杂芳基－氨基取代的四环素化合物
HK1041700A1 (zh) 新穎的丙二酸衍生物、其製備方法、其用途和含有它們的藥物組合物(xa因子活性抑制作用)
CN1293666A (zh) 苯硫酰胺衍生物及其作为药物的用途
CN1253474A (zh) 磺酰基二价芳基或杂芳基异羟肟酸化合物
CN1253555A (zh) 新的2－(亚氨基甲基)氨基－苯基衍生物,其制备方法、作为药物的应用及其药物组合物
CN1215055C (zh) 芳基磺酰氨基取代的异羟肟酸衍生物
CN1254478C (zh) 作为细胞吸附抑制剂的单糖衍生物
CN1309634A (zh) 肼衍生物
CN1058016C (zh) 氨基糖硫酸酯及其药学上可用的盐、其制备方法及其用途
CN1087285C (zh) 碱性基取代的苯甲酰胍，其制备方法，其作为药物或诊断试剂的用途，以及含有它们的药物
CN1805915A (zh) 作为药物活性剂的茚衍生物
CN1055920C (zh) 烷基苯甲酰基胍衍生物
CN1468215A (zh) 5-脒基-2-羟基苯磺酰胺衍生物,含有它的药用组合物以及制备它们用的中间体

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee